DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yau T, Kang YK, Kim TY. et al.
Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial.
JAMA Oncol 2020;
6 (11) e204564
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.